A solution (20 mL) containing 50 microM of EP-HMRG is orally administered once.
Sponsors
Maruyama Tatsuya
Conditions
Esophageal cancerHealthy adult male
Phase 1
Pharmacokinetic study of GCP-002 (EP-HMRG) in healthy adult males
Active, not recruitingJPRN-jRCT2031200085
Start: 2020-07-29Target: 6Updated: 2026-06-29
Additional pharmacokinetic study of GCP-002 (EP-HMRG) in healthy adult males
Active, not recruitingJPRN-jRCT2031200434
Start: 2021-03-23Target: 6Updated: 2026-06-29